Literature DB >> 15357789

The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation.

P H B Bolton-Maggs1, D J Perry, E A Chalmers, L A Parapia, J T Wilde, M D Williams, P W Collins, S Kitchen, G Dolan, A D Mumford.   

Abstract

The rare coagulation disorders are heritable abnormalities of haemostasis that may present significant difficulties in diagnosis and management. This review summarizes the current literature for disorders of fibrinogen, and deficiencies of prothrombin, factor V, FV + VIII, FVII, FX, the combined vitamin K-dependent factors, FXI and FXIII. Based on both collective clinical experience and the literature, guidelines for management of bleeding complications are suggested with specific advice for surgery, spontaneous bleeding, management of pregnancy and the neonate. We have chosen to include a section on Ehlers-Danlos Syndrome because haematologists may be consulted about bleeding manifestations in such patients.

Entities:  

Mesh:

Year:  2004        PMID: 15357789     DOI: 10.1111/j.1365-2516.2004.00944.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  73 in total

Review 1.  Fibrinogen replacement therapy: a critical review of the literature.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2011-11-15       Impact factor: 3.443

2.  Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Authors:  Stefania Vaglio; Domenico Prisco; Gianni Biancofiore; Daniela Rafanelli; Paola Antonioli; Michele Lisanti; Lorenzo Andreani; Leonardo Basso; Claudio Velati; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-15       Impact factor: 3.443

3.  Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.

Authors:  Giancarlo Maria Liumbruno; Maria Laura Sodini; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

Review 4.  Clinical use and the Italian demand for prothrombin complex concentrates.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Monica Lanzoni; Fabio Candura; Stefania Vaglio; Samantha Profili; Giuseppina Facco; Gabriele Calizzani; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

5.  A novel missense mutation Asp506Gly in Exon 13 of the F11 gene in an asymptomatic Korean woman with mild factor XI deficiency.

Authors:  Jong Ho Lee; Hee Soon Cho; Myung Soo Hyun; Hwa-Young Kim; Hee-Jin Kim
Journal:  Korean J Lab Med       Date:  2011-10-03

6.  Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates.

Authors:  Giancarlo Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

Review 7.  Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency.

Authors:  P James; O Salomon; D Mikovic; F Peyvandi
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

8.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

9.  4 Plasma for Therapeutic Use.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

10.  Uneventful cesarean delivery with administration of factor XI concentrate in a patient with severe factor XI deficiency.

Authors:  Georgios Mavromatidis; Konstantinos Dinas; Dimitrios Delkos; Fotios Goutzioulis; Christos Vosnakis; Emmanouel Hatzipantelis; Vassilia Garipidou; David Rousso
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.